ReviewFrontiers in pharmacology2026

Evidence for the use of anti-CD20 therapeutic antibodies in immune thrombotic thrombocytopenic purpura management: a review.

Konstantine Halkidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.